June 24, 2020 / 8:43 PM / 11 days ago

BRIEF-Sinovac Receives Approval From China For Its Quadrivalent Influenza Vaccine

June 24 (Reuters) - Sinovac Biotech Ltd:

* SINOVAC RECEIVES APPROVAL FROM CHINA FOR ITS QUADRIVALENT INFLUENZA VACCINE

* SINOVAC BIOTECH LTD - EXPECTS CO’S QUADRIVALENT INFLUENZA VACCINE TO BE AVAILABLE TO CHINA MARKET FOR 2020-2021 INFLUENZA SEASON Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below